Phase 2 Gastrointestinal Cancer Clinical Trials
15 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–15 of 15 trials
Recruiting
Phase 1Phase 2
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Pancreatic CancerGastric CancerColon Cancer+2 more
National Cancer Institute (NCI)110 enrolled1 locationNCT03190941
Recruiting
Phase 1Phase 2
Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02)
Gastrointestinal Cancer
Merck Sharp & Dohme LLC180 enrolled62 locationsNCT06596694
Recruiting
Phase 1Phase 2
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Hepatocellular CarcinomaNeuroendocrine TumorsGastrointestinal Cancer Metastatic
Teclison Ltd.25 enrolled2 locationsNCT02174549
Recruiting
Phase 2
A Study on the Effects of Exercise on Side Effects From Treatment for Gastrointestinal Cancers
Gastrointestinal Cancer
Memorial Sloan Kettering Cancer Center216 enrolled8 locationsNCT05789485
Recruiting
Phase 1Phase 2
Remote Resistance Exercise Powering Survivors - Gastrointestinal Oncology
Gastrointestinal Cancer
H. Lee Moffitt Cancer Center and Research Institute100 enrolled1 locationNCT05664178
Recruiting
Phase 1Phase 2
Evaluation of the Preliminary Efficacy and Safety of DR30206 in Combination With Standard Therapy in Patients With Gastrointestinal Cancer
Gastrointestinal Cancer
Zhejiang Doer Biologics Co., Ltd.186 enrolled1 locationNCT07056777
Recruiting
Phase 1Phase 2
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients
Pancreatic CancerGastric CancerColon Cancer+2 more
National Cancer Institute (NCI)70 enrolled1 locationNCT03745326
Recruiting
Phase 1Phase 2
Optimizing and Personalising Azacitidine Combination Therapy for Treating Solid Tumours QPOP and CURATE.AI
Breast CancerSolid TumorGastrointestinal Cancer
National University Hospital, Singapore10 enrolled1 locationNCT05381038
Recruiting
Phase 2
Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Malignant Tissue in Subjects Undergoing Surgical Resection for Cancer.
Gynecologic CancersEsophageal CancerGastrointestinal Cancers
John Waters50 enrolled1 locationNCT07039526
Recruiting
Phase 2
Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity
Breast CancerSarcomaLung Cancer+6 more
British Columbia Cancer Agency200 enrolled2 locationsNCT04273061
Recruiting
Phase 2
ChatBot and Activity Monitoring in Patients Undergoing Chemoradiotherapy
Lung CancerHead and Neck CancerGastrointestinal Cancer
Abramson Cancer Center at Penn Medicine70 enrolled1 locationNCT05318027
Recruiting
Phase 1Phase 2
OH2 Oncolytic Viral Therapy in Solid Tumors
Solid TumorGastrointestinal Cancer
Binhui Biopharmaceutical Co., Ltd.300 enrolled1 locationNCT03866525
Recruiting
Phase 2
SGM-101 in Colorectal Brain Metastases.
Colorectal NeoplasmsGastrointestinal CancerBrain Metastases+10 more
Leiden University Medical Center10 enrolled2 locationsNCT04755920
Recruiting
Phase 2
Pemigatinib in the Advanced Gastrointestinal Cancer With FGFR 1-3 Alterations
Gastrointestinal Cancer
Tianjin Medical University Cancer Institute and Hospital100 enrolled1 locationNCT05651672
Completed
Phase 2
Cancer Nutrition and Exercise rehabilitation program (CaNE) for patients with advanced cancer at risk of cancer cachexia syndrome – a phase II feasibility study
Patients with advanced lung cancerPatients with advanced upper gastrointestinal cancerCancer cachexia syndrome
The University of Sydney28 enrolled1 locationACTRN12615000951550